With safety surveillance being a core focus for all sponsors running RCTs, Data and Safety Monitoring Boards can be a powerful tool for evaluating and interpreting the vast amounts of data that are produced by RCTs. Protecting patients is the key focus of DSMBs. They help ensure the highest safety and efficacy by reviewing all study data, blinded and unblinded, and providing risk-benefit assessments throughout the study.
With over 20 years of experience managing DSMBs, PSI can help you answer and overcome the most common questions and challenges when determining whether and how to implement a DSMB. Contact our team today to discuss whether a DSMB is the right move for your upcoming clinical trial.
